Danial E. Baker
Impact in
-
- Diabetes Treatment and Management
- Diabetes Management and Research
- Gastroenterology top 5%
- Gastrointestinal motility and disorders
Papers in
- Pharmacology 132
- Pharmacy and Medical Practices 128
- Antibiotics Pharmacokinetics and Efficacy 14
- Toxicology 50
- Pharmacovigilance and Adverse Drug Reactions 50
- Co-authors
- Terri L. Levien (133 shared papers)Dennis J. Cada (122 shared papers)R. Keith Campbell (13 shared papers)Stephen M. Setter (5 shared papers)Jason L. Iltz (3 shared papers)George S. Jaresko (1 shared paper)Daniel C. Robinson (1 shared paper)John Raymond White (3 shared papers)
- Journals
- Hospital Pharmacy (209 papers)Annals of Pharmacotherapy (7 papers)The Science of Diabetes Self-Management and Care (4 papers)American Journal of Health-System Pharmacy (3 papers)Clinical Therapeutics (3 papers)
- Partner nations
- United StatesUnited Arab EmiratesBrazil
In The Last Decade
Danial E. Baker
247 papers receiving 1.5k citations
Peers
Comparison fields: 5 of 112
- Endocrinology, Diabetes and Metabolism 212
- Gastroenterology 86
- Pharmaceutical Science 70
- Pharmacology 67
- Hepatology 52
Countries citing papers authored by Danial E. Baker
This map shows the geographic impact of Danial E. Baker's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Danial E. Baker with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Danial E. Baker more than expected).
Fields of papers citing papers by Danial E. Baker
This network shows the impact of papers produced by Danial E. Baker. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Danial E. Baker. The network helps show where Danial E. Baker may publish in the future.
Co-authors
The 25 scholars most cited alongside Danial E. Baker, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 276 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2000 | 89 | |
| 2 | 2006 | 73 | |
| 3 | 1992 | 70 | |
| 4 | 2005 | 66 | |
| 5 | 2005 | 53 | |
| 6 | 2002 | 46 | |
| 7 | Pegylated interferon plus ribavirin for the treatment of chronic hepatitis C. | 2003 | 39 |
| 8 | Rifaximin: a nonabsorbed oral antibiotic. | 2005 | 38 |
| 9 | Adalimumab: human recombinant immunoglobulin g1 anti-tumor necrosis factor monoclonal antibody. | 2004 | 32 |
| 10 | 2013 | 32 | |
| 11 | 2001 | 29 | |
| 12 | Oxaliplatin: a new drug for the treatment of metastatic carcinoma of the colon or rectum. | 2003 | 26 |
| 13 | The short- and long-term safety of 5-aminosalicylate products in the treatment of ulcerative colitis. | 2004 | 23 |
| 14 | 2015 | 23 | |
| 15 | 2001 | 22 | |
| 16 | 1992 | 21 | |
| 17 | Alendronate and risedronate: what you need to know about their upper gastrointestinal tract toxicity. | 2002 | 21 |
| 18 | 2016 | 21 | |
| 19 | 2007 | 19 | |
| 20 | 2013 | 19 |
About Danial E. Baker
Danial E. Baker is a scholar working on Pharmacology, Toxicology, Pediatrics, Perinatology and Child Health, Endocrinology, Diabetes and Metabolism and Pharmacology, having authored 276 papers that have together received 1.6k indexed citations. Recurring topics across this work include Pharmacy and Medical Practices (128 papers), Pharmacovigilance and Adverse Drug Reactions (50 papers), Pharmaceutical studies and practices (42 papers), Pharmaceutical Economics and Policy (22 papers), Diabetes Treatment and Management (20 papers), Antibiotics Pharmacokinetics and Efficacy (14 papers), Medical research and treatments (13 papers) and Pain Management and Opioid Use (11 papers). The work is most often cited by research in Endocrinology, Diabetes and Metabolism (212 citations), Gastroenterology (86 citations), Pharmaceutical Science (70 citations), Pharmacology (67 citations) and Hepatology (52 citations). Danial E. Baker has collaborated with scholars based in United States, United Arab Emirates and Brazil. Frequent co-authors include Terri L. Levien, Dennis J. Cada, R. Keith Campbell, Stephen M. Setter, Jason L. Iltz, George S. Jaresko, Daniel C. Robinson, John Raymond White, James B. Leonard and Jack E. Fincham. Their work appears in journals such as Hospital Pharmacy, Annals of Pharmacotherapy, The Science of Diabetes Self-Management and Care, American Journal of Health-System Pharmacy and Clinical Therapeutics.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.